Retour
Fourchette du Jour
15,68 €
18,71 €
Fourchette 52 Semaines
2,88 €
24,00 €
Volume
853 969
Moyenne 50J / 200J
20,04 €
/
10,02 €
Clôture Précédente
18,63 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -7,2 | 0,3 |
| P/B | 2,1 | 2,9 |
| ROE % | -27,1 | 3,7 |
| Net Margin % | -896,1 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
42,50 €
+163.8%
Low: 23,00 €
High: 62,00 €
BPA Prévisionnel
-2,76 €
CA Est.
71 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
-3,59 €
-3,59 € – -3,59 €
|
1,5 M | 1 |
| FY2028 |
-3,07 €
-3,52 € – -2,59 €
|
1 M | 3 |
| FY2027 |
-2,73 €
-3,81 € – -0,24 €
|
20 M | 5 |
Points Clés
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -82,35M
PEG of 0,09 suggests growth is underpriced
Capital efficient — spends only 7,99% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-27,09%
ROIC-25,07%
Net Margin-896,11%
Op. Margin-1031,46%
Sécurité
Debt / Equity
0,02
Current Ratio14,24
Interest Coverage133,11
Valorisation
P/E Ratio
-7,17
P/B Ratio2,12
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 9,00M | Net Income (TTM) | -80,61M |
| ROE | -27,09% | ROA | -27,33% |
| Gross Margin | 0,00% | Operating Margin | -1031,46% |
| Net Margin | -896,11% | Free Cash Flow (TTM) | -82,35M |
| ROIC | -25,07% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 14,24 |
| Interest Coverage | 133,11 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,17 | P/B Ratio | 2,12 |
| P/S Ratio | 64,22 | PEG Ratio | 0,09 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 577,62M | Enterprise Value | 394,30M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 9,00M | 0,0 | 0,0 | 0,0 |
| Net Income | -80,61M | -71,11M | -63,85M | -39,72M |
| EPS (Diluted) | -2,24 | -6,63 | -8,55 | -5,32 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -92,78M | -78,19M | -48,40M | -39,97M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 294,89M | 358,23M | 25,92M | 28,43M |
| Total Liabilities | 22,84M | 35,11M | 199,32M | 140,99M |
| Shareholders' Equity | 272,05M | 323,13M | -173,40M | -112,56M |
| Total Debt | 5,56M | 8,70M | 53,25M | 2,47M |
| Cash & Equivalents | 188,89M | 354,35M | 21,64M | 27,64M |
| Current Assets | 286,79M | 357,10M | 25,31M | 28,03M |
| Current Liabilities | 20,14M | 27,78M | 58,17M | 5,86M |